Fennec Pharmaceuticals (FENC) Total Current Liabilities: 2011-2025
Historic Total Current Liabilities for Fennec Pharmaceuticals (FENC) over the last 12 years, with Sep 2025 value amounting to $9.8 million.
- Fennec Pharmaceuticals' Total Current Liabilities rose 32.01% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 32.01%. This contributed to the annual value of $6.9 million for FY2024, which is 8.39% down from last year.
- Per Fennec Pharmaceuticals' latest filing, its Total Current Liabilities stood at $9.8 million for Q3 2025, which was up 16.65% from $8.4 million recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Total Current Liabilities peaked at $9.8 million during Q1 2024, and registered a low of $848,000 during Q2 2021.
- In the last 3 years, Fennec Pharmaceuticals' Total Current Liabilities had a median value of $7.6 million in 2023 and averaged $7.1 million.
- In the last 5 years, Fennec Pharmaceuticals' Total Current Liabilities tumbled by 73.42% in 2021 and then skyrocketed by 258.14% in 2022.
- Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Total Current Liabilities stood at $2.0 million in 2021, then soared by 45.33% to $4.6 million in 2022, then surged by 63.88% to $7.6 million in 2023, then declined by 8.39% to $6.9 million in 2024, then surged by 32.01% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $8.4 million for Q2 2025, and $8.4 million during Q1 2025.